Benzinga
Benzinga
Benzinga
giovedì, settembre 24

Inspire Medical Systems Inc

INSPNYSE
Trade with Public
Trade with Public
$69.06
-2.24-3.14%
In chiusura: Sep 22, 5:00 PM EST
$69.10
-2.20-3.09%
Pre-mercato: 6:21 AM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Inspire Medical Systems Financials

Inspire Medical Systems (INSP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Avi Kapoor

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 analyst estimate..
Benzinga Newsdesk

PRO
Inspire Medical Systems Raises FY2026 Adj EPS Guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 Est; Raises FY2026 Sales Guidance from $825.000M-$875.000M to $835.000M-$875.000M vs $843.387M Est

Inspire Medical Systems (NYSE:INSP) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 analyst estimate. Raises FY2026 sales outlook from $825.000 million-$875.000 million to $835.000
Benzinga Newsdesk

PRO
Inspire Medical Systems Q2 Adj. EPS $0.14 Beats $(0.27) Estimate, Sales $200.581M Beat $194.671M Estimate

Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.27) by 151.85 percent. This is a 58.82 percent decrease over earnings of $0.34 per
Benzinga Newsdesk

Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.)
Rishabh Mishra

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 analyst estimate..
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved